BC
Buckley Capital Advisors, LLC
13F filer · CIK 0002111611Reported Aug 11, 2026
Net seller this quarter
13F portfolio value$161MU.S. long equity reported on 13F
Positions134 new · 5 closed
Net flow last quarter-$26.8MBuys minus sells
Top 10 positions weight96.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 11, 202613 positions | |||||
| $32.7M | 20.25% | 0.46% | -34.4% | Q4 2025 | |
| $21.3M | 13.20% | Not reported | -25.4% | Q4 2025 | |
| $20.3M | 12.58% | 0.30% | +15.9% | Q4 2025 | |
| $14.9M | 9.23% | 1.25% | New | Q2 2026 | |
| $14.8M | 9.14% | 0.20% | New | Q2 2026 | |
| $14M | 8.64% | 2.54% | -2.1% | Q4 2025 | |
| $12.5M | 7.77% | 0.31% | +88.9% | Q4 2025 | |
| $10.5M | 6.51% | 0.65% | +17.1% | Q4 2025 | |
| $8.97M | 5.55% | 1.24% | New | Q2 2026 | |
| $5.17M | 3.20% | 0.24% | +151.2% | Q1 2026 | |
| $2.97M | 1.84% | 0.16% | New | Q2 2026 | |
| $2.15M | 1.33% | 0.08% | -73.4% | Q4 2025 | |
| $556K | 0.34% | Not reported | -28.0% | Q4 2025 | |
| Q1 2026Reported May 15, 202614 positions | |||||
| $23.6M | 16.95% | 0.71% | -3.8% | Q4 2025 | |
| $15.6M | 11.18% | 0.73% | New | Q1 2026 | |
| $14M | 10.04% | 0.26% | +35.2% | Q4 2025 | |
| $13.4M | 9.59% | Not reported | +22.7% | Q4 2025 | |
| $10.1M | 7.25% | 2.60% | +19.4% | Q4 2025 | |
| $7.71M | 5.54% | 7.39% | +58.4% | Q4 2025 | |
| $6.68M | 4.80% | 0.58% | -54.7% | Q4 2025 | |
| STSLNOSoleno Therapeutics Inc | $6.08M | 4.37% | 0.35% | +21.9% | Q4 2025 |
| $5.34M | 3.84% | 0.32% | Not reported | Q4 2025 | |
| $4.96M | 3.56% | 0.16% | +2.1% | Q4 2025 | |
| $4.69M | 3.37% | 0.21% | -0.7% | Q4 2025 | |
| $3.95M | 2.84% | 0.19% | New | Q1 2026 | |
| $1.36M | 0.98% | 0.10% | New | Q1 2026 | |
| $747K | 0.54% | Not reported | -79.8% | Q4 2025 | |
| Q4 2025Reported Feb 17, 202613 positions | |||||
| $22.4M | 15.76% | 0.74% | New | Q4 2025 | |
| $13.8M | 9.74% | Not reported | New | Q4 2025 | |
| $11.7M | 8.26% | 1.27% | New | Q4 2025 | |
| $11.4M | 8.05% | 0.19% | New | Q4 2025 | |
| $9.75M | 6.86% | 2.18% | New | Q4 2025 | |
| $7.96M | 5.60% | 4.67% | New | Q4 2025 | |
| STSLNOSoleno Therapeutics Inc | $6.91M | 4.86% | 0.29% | New | Q4 2025 |
| $6.85M | 4.82% | 0.32% | New | Q4 2025 | |
| $6.33M | 4.45% | 0.21% | New | Q4 2025 | |
| $5.56M | 3.91% | 0.15% | New | Q4 2025 | |
| $4.95M | 3.48% | 1.14% | New | Q4 2025 | |
| $4.27M | 3.01% | 0.68% | New | Q4 2025 | |
| $3.01M | 2.12% | Not reported | New | Q4 2025 | |
Premium opens every quarter this fund has filed